Sequence 1340(Girentuximab)
From Wikisequences
| Sequence Girentuximab | |
|---|---|
| Target | carbonic anhydrase 9 (CA-IX) |
| Description | CG-250 , WX-G250 , Rencarex , Girentuximab , CA9-SCAN CG250
mab , source : chimeric |
| Design | Antibody |
| Chemistry | Amino acids |
| Sequence | Girentuximab light chain : DIVMTQSQRFMSTTVGDRVSITCKASQNVVSAVAWYQQKPGQSPKLLIYSASNRYTGVPDRFTGSGSGTDFTLTISNMQSEDLADFFCQQYSNYPWTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECxxxxx : |
| Application | clear cell renal cell carcinoma |
| Name | Girentuximab |
References
Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience. Hache M, Swoboda KJ, Sethna N, Farrow-Gillespie A, Khandji A, Xia S, Bishop KM. J Child Neurol. 2016 Jun;31(7):899-906. PubMed:26823478
Comments
Background
